Target intelligence / Profile preview

Tetanus toxin peptide epitope (null)

Target
null
Molecular classification
Other (linear peptide epitope), B-cell epitope, T-cell epitope
01

Overview

Tetanus toxin peptide epitopes are **short, linear amino acid sequences from the tetanus neurotoxin (TeNT) protein** that are recognized by antibodies or T cells, functioning as the critical immune determinants in responses to vaccination or infection with *Clostridium tetani*. Comprehensive mapping has identified dozens of both B cell and T cell epitopes, several of which are immunodominant and most frequently targeted after vaccination with tetanus toxoid[1][2][4][6]. These epitopes are used both in modern vaccines (as antigens in toxoids or as part of recombinant/multi-epitope designs) and in immunological diagnostic assays (e.g., peptide ELISA)[1]. Some epitopes, such as those in fragment C (TTFc), are particularly potent in eliciting a protective antibody response, interfering directly with toxin binding or enzymatic activity[1][2]. Mapping and selective use of these epitopes provide insight into immunological memory, guide vaccine design, and allow for monitoring of effective vaccination in populations.

Other names
Tetanus neurotoxin epitopeTeNT epitopeTetanus toxoid epitopeTT peptide epitopeTetanus-derived universal epitope
02

Mechanism of action

Induce neutralizing antibody responses that block tetanus neurotoxin activity or binding to neurons[1] Elicit T cell responses, including "universal" helper T cell epitopes that augment vaccine immunogenicity[3][4][6]

03

Biological functions

Immune response activation (through antibody and T cell stimulation[1][2][3][4][6])Vaccine antigenicityDiagnostics (serological monitoring and peptide ELISA[1])
04

Disease associations

Infection (targeted for immunity against tetanus[1][2][4][6])Other (primarily in vaccination and immune monitoring)
05

Safety considerations

Minimal for the peptide epitopes themselves (they are non-toxic and non-infectious)Potential for suboptimal immunogenicity if used alone rather than as part of a conjugate or multi-epitope formulation[1][2]
06

Interacting drugs

Tetanus toxoid vaccine

1 more in the full profile.

07

Biomarkers

Anti-tetanus IgG (levels assessed post-vaccination[1])Peptide-specific ELISA reactivity (for vaccine coverage assessment[1])

Beyond the preview

Go deeper on Tetanus toxin peptide epitope (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tetanus toxin peptide epitope (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call